Skip to main content
. 2020 Dec 10;21(24):9405. doi: 10.3390/ijms21249405

Figure 3.

Figure 3

Effects of Infigratinib/Bevacizumab on expression of the fibroblast growth factor receptor (FGFR) signaling pathway and proteins involved in cell cycle, proliferation, and apoptosis in HCC13-0109 and HCC06-0606 models. Mice bearing indicated xenografts were treated as described in Figure 1 for 5 days. Tumors were collected 2 h after the last treatments and tumor lysates subjected to Western blot analysis, as previously described [23]. Representative blots for HCC13-0109 (a) and HCC06-0606 (b) are shown.